External validation of the recommendations of the multidisciplinary consensus about inhaled therapies

Arch Bronconeumol. 2012 Jun;48(6):189-96. doi: 10.1016/j.arbres.2012.01.001. Epub 2012 Mar 2.
[Article in English, Spanish]

Abstract

The understanding of physicians and the skill of patients in the use of inhalers continues to be inadequate.

Objective: The external validation, by an expert panel, of practical clinical recommendations that had been developed in order to improve the knowledge and understanding of correct inhaled therapy use.

Methods: After a bibliographic review about inhaled therapies, 40 clinical recommendations were proposed. A two-round modified Delphi consensus was used to compare the opinions of a panel of 59 experts about the recommendations, which were grouped into 8 areas: general aspects (4), inhaled drugs (9), pressurized metered-dose and spacer inhalers (6), powder inhalers (4), nebulizers (3), devices for mechanical ventilation (3), inhalers for children (5) and issues related with compliance and education (6).

Results: After the first round of the consensus panel, 35 of the 40 recommendations analyzed were accepted. At the end of round 2, agreement was reached in 39 (97.5%). In 8 (20%), the consensus was unanimous (100%). Item 14 was deleted from the recommendations as consensus was not reached.

Conclusions: The external validation by experts in inhaled therapy found a high level of agreement with the clinical recommendations proposed. This consensus provides a tool that could contribute to the improved use of inhalers in our country in the future.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Delphi Technique
  • Humans
  • Practice Guidelines as Topic*
  • Respiratory Therapy / standards*